BWX Technologies, Inc.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $BWXT in the last 30 days.
See all $BWXT insider activity →BWX Technologies (BWXT) stock rose 7.7% after its BANR microreactor was selected for a project in Canada. Moody’s upgraded its outlook to positive. Analysts' views were mixed. The broader market also gained, with the S&P 500 up 0.9%.
BWX Technologies (BWXT) shares rose 8% after its BANR microreactor was selected for a nuclear power plant project in New Brunswick, Canada. The project, led by Prodigy Clean Energy and First Nations, aims to produce up to 50 MW of electricity by the early 2030s. BWXT will fabricate the reactor units at its Ontario facilities.
Prodigy Clean Energy and two Indigenous groups selected BWX Technologies' (BWXT) Advanced Nuclear Reactor for a 50 MW transportable nuclear power plant in Belledune, New Brunswick, Canada. The project, planned for the early 2030s, will be Indigenous-owned and aims to validate logistics and operations for potential mass deployment.
Over the past 7 days, AlphAI's AI scored 14 news stories mentioning BWXT (BWX Technologies, Inc.). Coverage has skewed bullish: 10 bullish, 3 neutral, and 1 bearish.
Recent BWXT coverage spans financial news, market movers and earnings.
The contract and credit upgrade provide fresh upside catalysts.
The contract award provides a new revenue stream and showcases BWXT's technology, likely supporting near‑term upside.
The contract validates BWXT's TNPP technology and could open a pipeline of similar projects across Canada and globally.
Analyst price target cut suggests downside pressure on the stock.
The pilot selection signals a strategic win for BWXT's microreactor program but lacks disclosed contract value.
AlphAI scores every news story that mentions BWXT with an AI model for sentiment and relevance, and aggregates insider trades from BWX Technologies, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
BWX Technologies (BWXT) stock rose 7.7% after its BANR microreactor was selected for a project in Canada. Moody’s upgraded its outlook to positive. Analysts' views were mixed. The broader market also gained, with the S&P 500 up 0.9%.
1 min readBWX Technologies (BWXT) shares rose 8% after its BANR microreactor was selected for a nuclear power plant project in New Brunswick, Canada. The project, led by Prodigy Clean Energy and First Nations, aims to produce up to 50 MW of electricity by the early 2030s. BWXT will fabricate the reactor units at its Ontario facilities.
1 min readProdigy Clean Energy and two Indigenous groups selected BWX Technologies' (BWXT) Advanced Nuclear Reactor for a 50 MW transportable nuclear power plant in Belledune, New Brunswick, Canada. The project, planned for the early 2030s, will be Indigenous-owned and aims to validate logistics and operations for potential mass deployment.
1 min readTruist Securities reduced its price target for BWX Technologies (NYSE:BWXT) to $182 from $202, maintaining a Hold rating. The adjustment follows the company's 2026 Investor Day, with the stock trading near its 52-week low at $135.35. BWXT operates in the nuclear sector and has been involved in recent defense initiatives. Multiple analysts have recently rated the stock, with targets ranging from $181 to $210.
2 min readBWX Technologies' BANR microreactor was chosen by Prodigy Clean Energy and two First Nations for a pilot project in Canada, aiming for operation by the early 2030s. The contract value was not disclosed.
1 min readMoody’s upgraded BWX Technologies' outlook to positive, citing its strong position in naval nuclear propulsion and stable financials. The company has an $8.4B backlog, 20% EBITDA margin, and $3.5B annual revenue. Moody’s expects BWXT to maintain leverage around 3x debt-to-EBITDA and free cash flow above $200M. A rating upgrade is possible if the company executes its growth strategy.
2 min readARK Innovation ETF, managed by Cathie Wood, bought $81M in Nvidia, $13.1M in Broadcom, and $7.3M in CoreWeave, while selling $111.1M in AMD. Other purchases included Intellia Therapeutics, BWX Technologies, and Tesla. Sales included 10x Genomics, Tempus AI, Alphabet, and Palantir.
2 min readBWX Technologies (NYSE:BWXT) has seen a 27% drop over three months, partly due to weaker-than-expected quarterly results. Jim Cramer discussed the stock's volatility, noting a recent analyst meeting with bullish long-term targets for 2030. The company plans to sell a majority stake in its medical isotope unit for up to $800 million, reallocating funds to nuclear manufacturing. BWXT projects 2030 revenues of $5.5B-$6B with EBITDA margins expanding to 20%.
2 min readBWX Technologies (BWXT) won an $189M contract to produce nuclear reactor fuel for the U.S. Navy. The work, to be done by subsidiary Nuclear Fuel Services, is expected to conclude by August 2027. BWXT supplies fuel and technology for various Navy submarines and aircraft carriers.
1 min readMaxim Group analyst Tate Sullivan maintained a Hold rating on BWX Technologies. The stock closed at $136.79. The average analyst price target is $212.30, implying a 55.20% upside. BWXT reported Q2 revenue of $901.63M and net profit of $89.01M, up from $764.04M and $78.39M last year.
1 min read
